
zzso zzso the new president zzso of the International Society of Cancer Gene zzso gave the conference summary and an overview of gene therapy in the new zzso The conference reflected the progress made in the development of new promoters and improved delivery systems for gene zzso Many presentations and posters focused on the progress in these zzso These scientific findings in the field of gene therapy may ultimately be exploited in the future developments of stem cell zzso zzso challenges still remain before gene therapy will significantly impact zzso The basic science of the cancer model systems lacked the ability to reflect the clinical reality of patient zzso This places the burden on the physicians to be more vigilant to subtle changes in patient response that were not observed in the zzso zzso The bystander effect has yet to be fully understood and needs further clinical zzso zzso delivery needs to be further addressed before a marketable product can be zzso The delivery systems discussed at the conference lack the ability to achieve pharmacological doses of therapeutic genes in the target zzso Until these challenges are zzso gene therapy will remain on the sidelines as a cancer zzso Yet, the field should be optimistic with the current zzso The future influences of the digital and zzso revolution in the health care industry will certainly impact the design of products for gene zzso zzso zzso concluded that the education of scientists would cross over into diverse disciplines so that novel observations will be exploited for new zzso This gene therapy series will continue with the International Conference on the Gene zzso of zzso scheduled for December zzso 2001, in San Diego, zzso 

